Cancer Drug Shortages Mean Higher Costs And Greater Risk For Patients | Latest News RSS feed

Cancer Drug Shortages Mean Higher Costs And Greater Risk For Patients - Latest News

Cancer drug shortages mean higher costs and greater risk for patients

A national survey of health professionals showed that drug shortages are taking a heavy toll on cancer patients, forcing treatment changes and delays that for some patients meant worse outcomes, more ... read more

Verastem: Too Cheap

Previous clinical failures mean ... Cancer Network (NCCN) published an updated guideline regarding the treatment of CLL. The NCCN guideline articulates the recommended first and second line treatment ... read more

Drug shortage crisis puts public health at risk

In a 2011 survey, the American Hospital Association reported that 82% of hospitals had to delay therapy due to a drug shortage ... the disease. Cancer drugs are commonly affected by shortages, often r... read more

Looking for another news?

A Marijuana Market Roundtable: What It Is, How Big Could It Be, and Top Stocks to Buy Now

We just had the first plant-based marijuana drug ... their cost. But there is nothing built into that scale that's going to prevent the price from dropping 20-40%. It will hurt. There's a very real ch... read more

The Case for a Non-Profit Single-Payer Healthcare System

Bankruptcy rates among cancer survivors are 260 percent higher than among similar households without cancer (Ramsay, 2016). 4. “It’s not uncommon for patients ... R&D Cost Estimates: MSF Response to T... read more

Drugmaker under fire for taxpayer-funded cancer drug that costs $129,269 a year

Two nonprofit groups have petitioned the federal government to take actions to increase the competition for a cancer drug ... also needs to be a greater focus on the critical challenge facing patients ... read more

Many US cancer patients struggle to afford life-saving medications

As cancer drug costs rise, U.S. cancer patients are more likely than other medical patients to struggle with paying for prescription medications, according to a recent study. The financial burdens are ... read more

18 Million Cancer Survivors Expected by 2022

An aging population coupled with improved treatment methods mean more people will survive cancer. But at what cost? The American ... of their disease. Cancer drug shortages are also becoming more comm... read more

How Big Pharma is slowing cancer research

For example, a 2013 study showed that patients who take a generic diabetes drug called metformin have a much lower risk of dying from prostate cancer. However ... are necessary to pay for the huge cos... read more

Using generic cancer drug could save many millions of dollars

The researchers, publishing online this month in the Journal of the National Cancer Institute, say that if all CML patients ... drugs physicians prescribe first, and they regularly do. Doing so here w... read more

FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us